Koninklijke DSM (OTCMKTS:RDSMY – Get Rating) – Research analysts at Jefferies Financial Group decreased their FY2022 earnings per share (EPS) estimates for Koninklijke DSM in a note issued to investors on Wednesday, September 14th. Jefferies Financial Group analyst C. Counihan now expects that the basic materials company will earn $0.87 per share for the year, down from their prior estimate of $1.26. Jefferies Financial Group currently has a “Buy” rating on the stock. The consensus estimate for Koninklijke DSM’s current full-year earnings is $1.17 per share. Jefferies Financial Group also issued estimates for Koninklijke DSM’s FY2024 earnings at $1.45 EPS.
A number of other brokerages have also commented on RDSMY. Sanford C. Bernstein upgraded Koninklijke DSM from a “market perform” rating to an “outperform” rating in a research note on Tuesday, June 14th. Deutsche Bank Aktiengesellschaft dropped their price objective on Koninklijke DSM from €205.00 ($209.18) to €180.00 ($183.67) and set a “buy” rating for the company in a research note on Friday, June 24th. Credit Suisse Group dropped their price objective on Koninklijke DSM from €182.00 ($185.71) to €162.00 ($165.31) and set an “outperform” rating for the company in a research note on Wednesday, July 13th. Finally, Barclays dropped their price objective on Koninklijke DSM from €189.00 ($192.86) to €188.00 ($191.84) in a research note on Wednesday, May 25th. One equities research analyst has rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $174.00.
Koninklijke DSM Stock Down 3.0 %
Koninklijke DSM Cuts Dividend
The firm also recently announced a dividend, which was paid on Friday, September 2nd. Stockholders of record on Friday, August 12th were issued a dividend of $0.1906 per share. This represents a dividend yield of 1.52%. The ex-dividend date was Thursday, August 11th.
About Koninklijke DSM
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments.
- Get a free copy of the StockNews.com research report on Koninklijke DSM (RDSMY)
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- 3 Banks Worth Considering For Q4
- MarketBeat: Week in Review 9/12 – 9/16
- No One Told These 3 Stocks It’s a Down Week
- Is There a Cure for What is Ailing Teladoc Stock?
Receive News & Ratings for Koninklijke DSM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke DSM and related companies with MarketBeat.com's FREE daily email newsletter.